Literature DB >> 20971080

Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1.

Zhonghua Xiang1, Ling Qiao, Yan Zhou, Lorne A Babiuk, Qiang Liu.   

Abstract

Steatosis is an important clinical manifestation of hepatitis C virus (HCV) infection. The molecular mechanisms of HCV-associated steatosis are not well understood. Sterol regulatory element-binding protein-1c (SREBP-1c) is a key transcription factor which activates the transcription of lipogenic genes. Here we showed that the nuclear, mature SREBP-1c level increases in the nucleus of replicon cells expressing HCV-3a nonstructural protein-5A (NS5A). We further showed that HCV-3a NS5A up-regulates SREBP-1c transcription. Additional analysis showed that transcriptional factor Sp1 is involved in SREBP-1c activation by HCV-3a NS5A because inhibition of Sp1 activity by mithramycin A or a dominant-negative Sp1 construct abrogated SREBP-1c promoter activation by HCV-3a NS5A. In addition, chromatin immunoprecipitation (ChIP) assay demonstrated enhanced binding of Sp1 on the SREBP-1c promoter in HCV-3a NS5A replicon cells. These results showed that HCV-3a NS5A activates SREBP-1c transcription through Sp1. Taken together, our results suggest that HCV-3a NS5A is a contributing factor for steatosis caused by HCV-3a infection.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971080     DOI: 10.1016/j.bbrc.2010.10.081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.

Authors:  Lance D Presser; Steven McRae; Gulam Waris
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 2.  Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.

Authors:  Steven W Johnson; Dorothea K Thompson; Brianne Raccor
Journal:  Curr Infect Dis Rep       Date:  2017-06       Impact factor: 3.725

Review 3.  Genotype 3 Infection: The Last Stand of Hepatitis C Virus.

Authors:  Austin Chan; Keyur Patel; Susanna Naggie
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

4.  Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus.

Authors:  Sandip K Bose; Hangeun Kim; Keith Meyer; Nathan Wolins; Nicholas O Davidson; Ranjit Ray
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

Review 5.  Theoretical basis of a beneficial role for vitamin D in viral hepatitis.

Authors:  Khanh vinh quốc Lương; Lan Thi Hoàng Nguyễn
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

6.  Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.

Authors:  Jawed Iqbal; Steven McRae; Krishna Banaudha; Thi Mai; Gulam Waris
Journal:  J Biol Chem       Date:  2013-11-15       Impact factor: 5.157

7.  GRIM-19 Restricts HCV Replication by Attenuating Intracellular Lipid Accumulation.

Authors:  Jung-Hee Kim; Pil S Sung; Eun B Lee; Wonhee Hur; Dong J Park; Eui-Cheol Shin; Marc P Windisch; Seung K Yoon
Journal:  Front Microbiol       Date:  2017-04-11       Impact factor: 5.640

8.  Individual co-variation between viral RNA load and gene expression reveals novel host factors during early dengue virus infection of the Aedes aegypti midgut.

Authors:  Vincent Raquin; Sarah Hélène Merkling; Valérie Gausson; Isabelle Moltini-Conclois; Lionel Frangeul; Hugo Varet; Marie-Agnès Dillies; Maria-Carla Saleh; Louis Lambrechts
Journal:  PLoS Negl Trop Dis       Date:  2017-12-19

Review 9.  Long Non-coding RNAs in Hepatitis C Virus-Infected Cells.

Authors:  Marina Barriocanal; Puri Fortes
Journal:  Front Microbiol       Date:  2017-09-28       Impact factor: 5.640

10.  Copy number variation of genes involved in the hepatitis C virus-human interactome.

Authors:  Lucyna Budzko; Malgorzata Marcinkowska-Swojak; Paulina Jackowiak; Piotr Kozlowski; Marek Figlerowicz
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.